EU Pharma Law

The Netherlands ∙ Proposed Solutions to Tackle Expensive Medicines in The Netherlands: A Critical Review

If you have an interest in Life Sciences, I am glad to draw your attention to my Report in the latest edition of the European Pharmaceutical Law Review (EPLR). As many of you know, the cost of medicines is a frequent subject of debate in the Netherlands. In order to find solutions to this recurring issue, a report was published by the Council for Public Healthcare and Society (RVS), proposing compulsory patent licensing and the wider application of the compounding exemption (formula magistralis) as possible solutions. Please find my (critical) review here.